Neutralizing and non-neutralizing antibody responses in HIV-1 subtype C chronically infected patients with divergent rates of disease progression حسب Archary, D, Rong, R, Gordon, M, Boliar, S, Gray, E, Dugast, A, Hermanus, T, Goulder, P, Coovadia, H, Morris, L, Alter, G, Derdeyn, C, Ndung'u, T

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection. حسب Archary, D, Rong, R, Gordon, M, Boliar, S, Madiga, M, Gray, E, Dugast, A, Hermanus, T, Goulder, P, Coovadia, H, Werner, L, Morris, L, Alter, G, Derdeyn, C, Ndung'u, T

Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection حسب Archary, D, Rong, R, Gordon, M, Boliar, S, Madiga, M, Gray, E, Dugast, A, Hermanus, T, Goulder, P, Coovadia, H, Werner, L, Morris, L, Alter, G, Derdeyn, C, Ndung'u, T

Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity حسب Ackerman, M, Crispin, M, Yu, X, Baruah, K, Boesch, A, Harvey, D, Dugast, A, Heizen, E, Ercan, A, Choi, I, Streeck, H, Nigrovic, P, Bailey-Kellogg, C, Scanlan, C, Alter, G